What is FluidForm?
Based in the Boston biotechnology hub, FluidForm operates at the intersection of advanced manufacturing and life sciences. The company is recognized for its patented FRESH (Freeform Reversible Embedding of Suspended Hydrogels) 3D printing platform, a technology that has garnered significant attention in peer-reviewed literature for its ability to fabricate functional human tissue. FluidForm's operational focus is twofold: providing high-fidelity tissue models for pharmaceutical drug efficacy and cardiotoxicity testing, and developing long-term solutions for organ replacement. By addressing critical gaps in preclinical testing and implantable device technology, the company serves as a vital link in the modern healthcare supply chain, aiming to reduce reliance on traditional animal models while improving patient outcomes through bio-engineered solutions.
How much funding has FluidForm raised?
FluidForm has raised a total of $310K across 2 funding rounds:
Debt
$150K
Debt
$160K
Debt (2020): $150K with participation from PPP
Debt (2021): $160K led by PPP
Key Investors in FluidForm
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for FluidForm?
With the recent capital deployment, FluidForm is positioned to accelerate its preclinical programs and expand its footprint in the medical device market. The strategic roadmap involves refining the scalability of its biofabrication processes to meet the rigorous demands of clinical-grade manufacturing. As the company moves deeper into its late-stage lifecycle, the focus will likely shift toward regulatory milestones and potential partnerships with major pharmaceutical entities seeking to integrate advanced tissue models into their drug discovery pipelines. The successful execution of these initiatives will be pivotal in determining the company's long-term viability as a leader in the regenerative medicine landscape, ultimately aiming to bridge the gap between laboratory innovation and clinical application.
See full FluidForm company page
